Cohance Lifesciences Limited
COHANCE
株式のランク
#6361
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
株価
$5.06
最終同期: 2026-10-19
時価総額
$1.93B
変化（1日）
-1.34%
変化（1年）
-57.33%
国
IN
取引 Cohance Lifesciences Limited (COHANCE)
カテゴリー
Healthcare
Cohance Lifesciences Limited（COHANCE）のEPS
June 2025 時点のEPS TTM: $0.11
Cohance Lifesciences Limitedの最新の財務報告と株価によると、同社の現在のEPS（TTM）は$0.11です。2024年末には、EPSは$0.14で、2023年のEPS$0.20と減少でした。
Cohance Lifesciences LimitedのEPS履歴（2019から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
